Neurocrine Biosciences (NBIX) Selling, General & Administrative (2010 - 2026)
Neurocrine Biosciences (NBIX) Selling, General & Administrative (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 304.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 588.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 184.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 18.47 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 318.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 381.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 264.59 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 57.53 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 109.67 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 46.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 318.50 Mn |
| Dec 31, 2025 | 301.80 Mn |
| Sep 30, 2025 | 291.60 Mn |
| Jun 30, 2025 | 286.30 Mn |
| Mar 31, 2025 | 276.50 Mn |
| Dec 31, 2024 | 287.80 Mn |
| Sep 30, 2024 | 234.30 Mn |
| Jun 30, 2024 | 242.00 Mn |
| Mar 31, 2024 | 243.10 Mn |
| Dec 31, 2023 | 218.90 Mn |
| Sep 30, 2023 | 204.20 Mn |
| Jun 30, 2023 | 221.80 Mn |
| Mar 31, 2023 | 242.70 Mn |
| Dec 31, 2022 | 182.90 Mn |
| Sep 30, 2022 | 186.30 Mn |
| Jun 30, 2022 | 182.80 Mn |
| Mar 31, 2022 | 200.70 Mn |
| Dec 31, 2021 | 156.50 Mn |
| Sep 30, 2021 | 154.60 Mn |
| Jun 30, 2021 | 143.20 Mn |